Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat
NCT ID: NCT05016674
Last Updated: 2024-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2021-07-21
2023-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Becker Continued Access Study
NCT01286870
Histologic Evaluation of Tissue Following Lutronic System Exposure
NCT04207047
Clinical Study to Evaluate the Safety and Efficacy of the Vela100
NCT01026441
Lutronic PicoPlus Exploratory Clinical Trial
NCT03415685
Study Where Healthy Volunteers Evaluate LoFric Catheters
NCT00802750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laser-assisted liposuction
Laser-Assisted Liposuction with the LipoLife system.
LipoLife system
Abdominal Laser-Assisted Liposuction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LipoLife system
Abdominal Laser-Assisted Liposuction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Between 18 and 70 years of age.
3. Estimated fat harvesting of at least 300 milliliters.
4. Provided written Informed Consent.
Exclusion Criteria
2. Current smoker.
3. Presence of known malignancy.
4. Active infection in the treatment area.
5. History of autoimmune disorder (e.g., Systemic Lupus Erythematosus \[SLE\]).
6. History of connective, metabolic, or atrophic skin disease.
7. History of keloid scarring.
8. Chronic use (\>7 consecutive days) of anticoagulants (such as aspirin) or NSAIDs within 15 days before enrollment.
9. Subjects with immune system diseases.
10. Any other reason that in the opinion of the investigator, prevents the subject from participating in the study or compromises the subject safety.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alma Lasers
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Jason Martin, MD
Role: PRINCIPAL_INVESTIGATOR
Jason Martin, M.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
William Jason Martin, MD
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ALM-Lipo-VorFat-21-013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.